6.39
-0.99 (-13.41%)
-0.99 (-13.41%)
Upgrade to Real-Time
Regular Market
Low
2.10
High
24.90
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Vaxart Inc | VXRT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.99 | -13.41% | 6.39 | 11:07:16 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 6.80 | 6.33 | 6.80 | 7.38 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 6.39 | 6.40 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 38,009 | 11,018,518 | $ 6.53 | $ 71,961,463 | 26,752,211 | 2.10 - 24.90 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:07:21 | 400 | $ 6.39 | USD |
Vaxart Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 752.35M | 117.77M | 91.83M | $ 4.05M | $ - | -0.35 | -30.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | -150.00k | 2.30% |
Vaxart News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VXRT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 9.69 | 11.108 | 6.33 | 9.13 | 86,777,311 | -3.30 | -34.06% |
| 1 Month | 5.80 | 11.108 | 4.862 | 8.61 | 37,742,655 | 0.59 | 10.17% |
| 3 Months | 8.41 | 11.108 | 4.862 | 8.19 | 16,899,703 | -2.02 | -24.02% |
| 6 Months | 5.20 | 24.90 | 3.50 | 8.73 | 16,852,440 | 1.19 | 22.88% |
| 1 Year | 2.62 | 24.90 | 2.10 | 8.71 | 18,708,842 | 3.77 | 143.89% |
| 3 Years | 5.47 | 24.90 | 0.2543 | 7.40 | 7,778,027 | 0.92 | 16.82% |
| 5 Years | 16.83 | 24.90 | 0.2543 | 7.41 | 4,830,522 | -10.44 | -62.03% |
Vaxart Description
| Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States. |
